Programmed death-1 impairs secondary effector lung CD8+ T cells during respiratory virus reinfection

Journal of Immunology

Volumn 193, Issue 10, 2014, Pages 5108-5117

  Erickson, John J ^a   Rogers, Meredith C ^a   Hastings, Andrew K ^a   Tollefson, Sharon J ^a   Williams, John V ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; PROGRAMMED DEATH 1 RECEPTOR; CD223 ANTIGEN; CD244 PROTEIN, MOUSE; IMMUNOGLOBULIN RECEPTOR; LEUKOCYTE ANTIGEN; PDCD1 PROTEIN, MOUSE; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEGRANULATION; EFFECTOR CELL; FEMALE; HUMAN METAPNEUMOVIRUS; HUMAN METAPNEUMOVIRUS INFECTION; HUMORAL IMMUNITY; IMMUNE RESPONSE; INFLUENZA VIRUS; LOWER RESPIRATORY TRACT INFECTION; LUNG ALVEOLUS CELL; MALE; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIMARY INFECTION; PROTEIN EXPRESSION; REINFECTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SECONDARY INFECTION; SIGNAL TRANSDUCTION; VIRAL CLEARANCE; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TITRATION; ANIMAL; B LYMPHOCYTE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNE EVASION; IMMUNOLOGY; LUNG; LYMPHOCYTE COUNT; METAPNEUMOVIRUS; ORTHOMYXOVIRUS; ORTHOMYXOVIRUS INFECTION; PARAMYXOVIRIDAE INFECTIONS; PATHOLOGY; RESPIRATORY TRACT INFECTION; VIROLOGY; VIRUS LOAD;

ANIMALS; ANTIGENS, CD; B-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DEGRANULATION; GENE EXPRESSION REGULATION; HUMANS; IMMUNE EVASION; LUNG; LYMPHOCYTE COUNT; METAPNEUMOVIRUS; MICE; ORTHOMYXOVIRIDAE; ORTHOMYXOVIRIDAE INFECTIONS; PARAMYXOVIRIDAE INFECTIONS; PROGRAMMED CELL DEATH 1 RECEPTOR; RECEPTORS, IMMUNOLOGIC; RESPIRATORY TRACT INFECTIONS; SIGNAL TRANSDUCTION; VIRAL LOAD; VIRAL VACCINES; VIRUS REPLICATION;

EID: 84910112477     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302208     Document Type: Article

References (54)

1. Papenburg, J., M. E. Hamelin, N. Ouhoummane, J. Carbonneau, M. Ouakki, F. Raymond, L. Robitaille, J. Corbeil, G. Caouette, L. Frenette, et al. 2012. Comparison of risk factors for human metapneumovirus and respiratory syncytial virus disease severity in young children. J. Infect. Dis. 206: 178-189.
2. Shahda, S., W. G. Carlos, P. J. Kiel, B. A. Khan, and C. A. Hage. 2011. The human metapneumovirus: a case series and review of the literature. Transpl. Infect. Dis. 13: 324-328.
3. Sloots, T. P., I. M. Mackay, S. Bialasiewicz, K. C. Jacob, E. McQueen, G. B. Harnett, D. J. Siebert, B. I. Masters, P. R. Young, and M. D. Nissen. 2006. Human metapneumovirus, Australia, 2001-2004. Emerg. Infect. Dis. 12: 1263-1266.
4. Walsh, E. E., D. R. Peterson, and A. R. Falsey. 2008. Human metapneumovirus infections in adults: another piece of the puzzle. Arch. Intern. Med. 168: 2489-2496.
5. Widmer, K., Y. Zhu, J. V. Williams, M. R. Griffin, K. M. Edwards, and H. K. Talbot. 2012. Rates of hospitalizations for respiratory syncytial virus, human metapneumovirus, and influenza virus in older adults. J. Infect. Dis. 206: 56-62.
6. Williams, J. V., P. A. Harris, S. J. Tollefson, L. L. Halburnt-Rush, J. M. Pingsterhaus, K. M. Edwards, P. F. Wright, and J. E. Crowe, Jr. 2004. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N. Engl. J. Med. 350: 443-450.
7. Williams, J. V., R. Martino, N. Rabella, M. Otegui, R. Parody, J. M. Heck, and J. E. Crowe, Jr. 2005. A prospective study comparing human metapneumovirus with other respiratory viruses in adults with hematologic malignancies and respiratory tract infections. J. Infect. Dis. 192: 1061-1065.
8. Williams, J. V., C. K. Wang, C. F. Yang, S. J. Tollefson, F. S. House, J. M. Heck, M. Chu, J. B. Brown, L. D. Lintao, J. D. Quinto, et al. 2006. The role of human metapneumovirus in upper respiratory tract infections in children: a 20-year experience. J. Infect. Dis. 193: 387-395.
9. van den Hoogen, B. G., J. C. de Jong, J. Groen, T. Kuiken, R. de Groot, R. A. Fouchier, and A. D. Osterhaus. 2001. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat. Med. 7: 719-724.
10. Pavlin, J. A., A. C. Hickey, N. Ulbrandt, Y. P. Chan, T. P. Endy, M. S. Boukhvalova, S. Chunsuttiwat, A. Nisalak, D. H. Libraty, S. Green, et al. 2008. Human metapneumovirus reinfection among children in Thailand determined by ELISA using purified soluble fusion protein. J. Infect. Dis. 198: 836-842.
11. Yang, C. F., C. K. Wang, S. J. Tollefson, R. Piyaratna, L. D. Lintao, M. Chu, A. Liem, M. Mark, R. R. Spaete, J. E. Crowe, Jr., and J. V. Williams. 2009. Genetic diversity and evolution of human metapneumovirus fusion protein over twenty years. Virol. J. 6: 138.
12. Kroll, J. L., and A. Weinberg. 2011. Human metapneumovirus. Semin. Respir. Crit. Care Med. 32: 447-453.
13. Johnson, K. M., R. M. Chanock, D. Rifkind, H. M. Kravetz, and V. Knight. 1961. Respiratory syncytial virus. IV. Correlation of virus shedding, serologic response, and illness in adult volunteers. JAMA 176: 663-667.
14. Hall, C. B., E. E. Walsh, C. E. Long, and K. C. Schnabel. 1991. Immunity to and frequency of reinfection with respiratory syncytial virus. J. Infect. Dis. 163: 693-698.
15. Okamoto, M., K. Sugawara, E. Takashita, Y. Muraki, S. Hongo, H. Nishimura, and Y. Matsuzaki. 2010. Longitudinal course of human metapneumovirus antibody titers and reinfection in healthy adults. J. Med. Virol. 82: 2092-2096.
16. Skiadopoulos, M. H., S. Biacchesi, U. J. Buchholz, J. M. Riggs, S. R. Surman, E. Amaro-Carambot, J. M. McAuliffe, W. R. Elkins, M. St Claire, P. L. Collins, and B. R. Murphy. 2004. The two major human metapneumovirus genetic lineages are highly related antigenically, and the fusion (F) protein is a major contributor to this antigenic relatedness. J. Virol. 78: 6927-6937.
17. Wyde, P. R., S. N. Chetty, A. M. Jewell, S. L. Schoonover, and P. A. Piedra. 2005. Development of a cotton rat-human metapneumovirus (hMPV) model for identifying and evaluating potential hMPVantivirals and vaccines. Antiviral Res. 66: 57-66.
18. Kolli, D., E. L. Bataki, L. Spetch, A. Guerrero-Plata, A. M. Jewell, P. A. Piedra, G. N. Milligan, R. P. Garofalo, and A. Casola. 2008. T lymphocytes contribute to antiviral immunity and pathogenesis in experimental human metapneumovirus infection. J. Virol. 82: 8560-8569.
19. + T cells through PD-1. J. Clin. Invest. 122: 2967-2982.
20. Chang, J., and T. J. Braciale. 2002. Respiratory syncytial virus infection suppresses lung CD8+ T-cell effector activity and peripheral CD8+ T-cell memory in the respiratory tract. Nat. Med. 8: 54-60.
21. Vallbracht, S., H. Unsöld, and S. Ehl. 2006. Functional impairment of cytotoxic T cells in the lung airways following respiratory virus infections. Eur. J. Immunol. 36: 1434-1442.
22. Wherry, E. J. 2011. T cell exhaustion. Nat. Immunol. 12: 492-499.
23. Francisco, L. M., P. T. Sage, and A. H. Sharpe. 2010. The PD-1 pathway in tolerance and autoimmunity. Immunol. Rev. 236: 219-242.
24. Hamid, O., C. Robert, A. Daud, F. S. Hodi, W. J. Hwu, R. Kefford, J. D. Wolchok, P. Hersey, R. W. Joseph, J. S. Weber, et al. 2013. Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma. N. Engl. J. Med. 369: 134-144.
25. Topalian, S. L., F. S. Hodi, J. R. Brahmer, S. N. Gettinger, D. C. Smith, D. F. McDermott, J. D. Powderly, R. D. Carvajal, J. A. Sosman, M. B. Atkins, et al. 2012. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N. Engl. J. Med. 366: 2443-2454.
26. + T cells limits their effectiveness during sustained high viral load. Immunity 35: 285-298.
27. Odorizzi, P. M., and E. J. Wherry. 2012. Inhibitory receptors on lymphocytes: insights from infections. J. Immunol. 188: 2957-2965.
28. Jin, H. T., A. C. Anderson, W. G. Tan, E. E. West, S. J. Ha, K. Araki, G. J. Freeman, V. K. Kuchroo, and R. Ahmed. 2010. Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection. Proc. Natl. Acad. Sci. USA 107: 14733-14738.
29. + T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat. Immunol. 10: 29-37.
30. Nakamoto, N., H. Cho, A. Shaked, K. Olthoff, M. E. Valiga, M. Kaminski, E. Gostick, D. A. Price, G. J. Freeman, E. J. Wherry, and K. M. Chang. 2009. Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade. PLoS Pathog. 5: e1000313.
31. Sharma, S., A. Sundararajan, A. Suryawanshi, N. Kumar, T. Veiga-Parga, V. K. Kuchroo, P. G. Thomas, M. Y. Sangster, and B. T. Rouse. 2011. T cell immunoglobulin and mucin protein-3 (Tim-3)/Galectin-9 interaction regulates influenza A virus-specific humoral and CD8 T-cell responses. Proc. Natl. Acad. Sci. USA 108: 19001-19006.
32. Workman, C. J., L. S. Cauley, I. J. Kim, M. A. Blackman, D. L. Woodland, and D. A. Vignali. 2004. Lymphocyte activation gene-3 (CD223) regulates the size of the expanding T cell population following antigen activation in vivo. J. Immunol. 172: 5450-5455.
33. Williams, J. V., S. J. Tollefson, J. E. Johnson, and J. E. Crowe, Jr. 2005. The cotton rat (Sigmodon hispidus) is a permissive small animal model of human metapneumovirus infection, pathogenesis, and protective immunity. J. Virol. 79: 10944-10951.
34. + T cells. Immunity 35: 400-412.
35. Rock, M. T., and J. E. Crowe, Jr. 2003. Identification of a novel human leucocyte antigen-A∗01-restricted cytotoxic T-lymphocyte epitope in the respiratory syncytial virus fusion protein. Immunology 108: 474-480.
36. Graham, B. S., L. A. Bunton, P. F. Wright, and D. T. Karzon. 1991. Reinfection of mice with respiratory syncytial virus. J. Med. Virol. 34: 7-13.
37. Prince, G. A., J. P. Prieels, M. Slaoui, and D. D. Porter. 1999. Pulmonary lesions in primary respiratory syncytial virus infection, reinfection, and vaccineenhanced disease in the cotton rat (Sigmodon hispidus). Lab. Invest. 79: 1385-1392.
38. Graham, M. B., and T. J. Braciale. 1997. Resistance to and recovery from lethal influenza virus infection in B lymphocyte-deficient mice. J. Exp. Med. 186: 2063-2068.
39. Epstein, S. L., C. Y. Lo, J. A. Misplon, and J. R. Bennink. 1998. Mechanism of protective immunity against influenza virus infection in mice without antibodies. J. Immunol. 160: 322-327.
40. Collins, P. L., and J. A. Melero. 2011. Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years. Virus Res. 162: 80-99.
41. Lee, S., K. L. Stokes, M. G. Currier, K. Sakamoto, N. W. Lukacs, E. Celis, and M. L. Moore. 2012. Vaccine-elicited CD8+ T cells protect against respiratory syncytial virus strain A2-line19F-induced pathogenesis in BALB/c mice. J. Virol. 86: 13016-13024.
42. Green, D. R., N. Droin, and M. Pinkoski. 2003. Activation-induced cell death in T cells. Immunol. Rev. 193: 70-81.
43. Cho, H. I., and E. Celis. 2009. Optimized peptide vaccines eliciting extensive CD8 T-cell responses with therapeutic antitumor effects. Cancer Res. 69: 9012-9019.
44. Smith, D. J., A. S. Lapedes, J. C. de Jong, T. M. Bestebroer, G. F. Rimmelzwaan, A. D. Osterhaus, and R. A. Fouchier. 2004. Mapping the antigenic and genetic evolution of influenza virus. Science 305: 371-376.
45. García, O., M. Martín, J. Dopazo, J. Arbiza, S. Frabasile, J. Russi, M. Hortal, P. Perez-Breña, I. Martínez, B. García-Barreno, et al. 1994. Evolutionary pattern of human respiratory syncytial virus (subgroup A): cocirculating lineages and correlation of genetic and antigenic changes in the G glycoprotein. J. Virol. 68: 5448-5459.
46. Yang, C. F., C. K. Wang, S. J. Tollefson, L. D. Lintao, A. Liem, M. Chu, and J. V. Williams. 2013. Human metapneumovirus G protein is highly conserved within but not between genetic lineages. Arch. Virol. 158: 1245-1252.
47. Falsey, A. R., P. A. Hennessey, M. A. Formica, M. M. Criddle, J. M. Biear, and E. E. Walsh. 2010. Humoral immunity to human metapneumovirus infection in adults. Vaccine 28: 1477-1480.
48. Englund, J. A., M. Boeckh, J. Kuypers, W. G. Nichols, R. C. Hackman, R. A. Morrow, D. N. Fredricks, and L. Corey. 2006. Brief communication: fatal human metapneumovirus infection in stem-cell transplant recipients. Ann. Intern. Med. 144: 344-349.
49. Madhi, S. A., H. Ludewick, L. Kuwanda, N. van Niekerk, C. Cutland, and K. P. Klugman. 2007. Seasonality, incidence, and repeat human metapneumovirus lower respiratory tract infections in an area with a high prevalence of human immunodeficiency virus type-1 infection. Pediatr. Infect. Dis. J. 26: 693-699.
50. Chlewicki, L. K., C. A. Velikovsky, V. Balakrishnan, R. A. Mariuzza, and V. Kumar. 2008. Molecular basis of the dual functions of 2B4 (CD244). J. Immunol. 180: 8159-8167.
51. Wei, F., S. Zhong, Z. Ma, H. Kong, A. Medvec, R. Ahmed, G. J. Freeman, M. Krogsgaard, and J. L. Riley. 2013. Strength of PD-1 signaling differentially affects T-cell effector functions. Proc. Natl. Acad. Sci. USA 110: E2480-E2489.
52. Shulzhenko, N., A. Morgun, W. Hsiao, M. Battle, M. Yao, O. Gavrilova, M. Orandle, L. Mayer, A. J. Macpherson, K. D. McCoy, et al. 2011. Crosstalk between B lymphocytes, microbiota and the intestinal epithelium governs immunity versus metabolism in the gut. Nat. Med. 17: 1585-1593.
53. Barber, D. L., E. J. Wherry, D. Masopust, B. Zhu, J. P. Allison, A. H. Sharpe, G. J. Freeman, and R. Ahmed. 2006. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439: 682-687.
54. Wherry, E. J., J. N. Blattman, K. Murali-Krishna, R. van der Most, and R. Ahmed. 2003. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J. Virol. 77: 4911-4927.